Lessing Andrés J, Cote Gregory M, DeLaney Thomas F, Plotkin Scott R, Raskin Kevin A, Lessing Juan N
Neurofibromatosis Northeast, Burlington, Massachusetts, USA.
Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Case Rep Oncol. 2021 Sep 20;14(3):1342-1346. doi: 10.1159/000518317. eCollection 2021 Sep-Dec.
Pseudoprogression, defined as the radiographic false appearance of disease progression, is not frequently observed in patients with malignant peripheral nerve sheath tumor (MPNST). We report on a case of a patient with neurofibromatosis type 1 (NF1) MPNST pseudoprogression that presented as suspected local recurrence 9.5 years after last treatment. The patient underwent surgical resection following growth of a mass on sequential MRI imaging; surgical pathology, however, showed skeletal muscle with atrophy, fibroadipose tissue, and fat necrosis, without any evidence of tumor. As MPNST survival rates increase, physicians should consider pseudoprogression as a potential presentation after prior treatment.
假性进展被定义为疾病进展的影像学假像,在恶性外周神经鞘瘤(MPNST)患者中并不常见。我们报告了一例1型神经纤维瘤病(NF1)MPNST假性进展的病例,该患者在最后一次治疗9.5年后出现疑似局部复发。在连续的MRI成像显示肿块生长后,患者接受了手术切除;然而,手术病理显示为骨骼肌萎缩、纤维脂肪组织和脂肪坏死,没有任何肿瘤迹象。随着MPNST生存率的提高,医生应将假性进展视为先前治疗后的一种可能表现。